EUVIMEDEUVIMED entdecken
Crossref

The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99m Tc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1

Sergey Deyev, Anastasia Fominykh, Ruslan Varvashenya iD, Gleb Yanovich, Vitalina Bodenko, Evgenii Plotnikov, Mariia Tretyakova, Daria Eskova iD, Roman Zhelchan, Alexey Schulga, Elena Konovalova, Rustam Ziganshin und 4 weitere

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Sergey Deyev und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russ…. Hauptthemen laut MEDLINE: Epithelial Cell Adhesion Molecule, Ankyrin Repeat, Technetium, Glycine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Tomsk Polytechnic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive radionuclide imaging of epithelial cell adhesion molecule (EpCAM) expression in lung, ovarian, breast, kidney, and other cancers can stratify patients for EpCAM-targeted therapy. The constructed scaffold proteins, designed ankyrin repeat proteins (DARPins), are highly specific high-affinity probes for radionuclide imaging. A clinical study demonstrated that the anti-EpCAM DARPin [99mTc]Tc-(HE)3-Ec1 showed precise EpCAM imaging at 2, 4, and 6 h after injection in patients with nonsmall cell lung cancer. However, a noticeable accumulation in healthy organs has prompted the development of new Ec1-based agents with improved biodistribution properties. In addition, it would be desirable to substitute a labor-intensive labeling procedure. The purpose of this study was to test the hypothesis that the use of Gly-Gly-Gly-Cys (G3C) or Glu-Glu-Glu-Cys (E3C) peptide chelators placed at the C-terminus of DARPin for labeling with 99mTc (V) could improve the image contrast and biodistribution of Ec1. The radiochemical yield of the new variants exceeded 95%. The labeled proteins specifically bound to human EpCAM-expressing cancer cell lines with affinities of 8-10 nM. The biodistribution of [99mTc]Tc-Ec1-G3C and [99mTc]Tc-Ec1-E3C in mice was compared with the biodistribution of clinically tested [99mTc]Tc-(HE)3-Ec1 in a Nu/j mouse model with SKOV-3 xenografts. The new variants specifically accumulate in human xenografts with EpCAM expression. The accumulation of new variants in healthy organs (liver, salivary glands, spleen, and stomach) was reduced compared to [99mTc]Tc-(HE)3-Ec1. [99mTc]Tc-Ec1-G3C provided the best imaging contrast and is suitable for clinical testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial Cell Adhesion MoleculeAnkyrin RepeatTechnetiumGlycineChelating AgentsPeptidesAnimalsHumansMiceTissue DistributionCell Line, TumorFemaleRadiopharmaceuticalsMice, NudeRadionuclide Imaging

Stichwörter der Autor:innen

99mTcDARPin Ec1ESPEpCAMengineered scaffold proteinsradionuclide molecular imaging

Substanzen

Epithelial Cell Adhesion MoleculeTechnetiumGlycineChelating AgentsRadiopharmaceuticalsPeptides

Autor:innen und Institutionen

  • Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Molecular Immunology Laboratory, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634009 Tomsk, Russia.
  • Collective Use Center "Bioorganic", Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden.
  • Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia.

ORCID-Profile: Ruslan Varvashenya, Daria Eskova, Anna Orlova, Vladimir Tolmachev, Mariia Larkina

Förderung

  • Tomsk Polytechnic University

Zitieren

APA

Deyev, S., Fominykh, A., Varvashenya, R., Yanovich, G., Bodenko, V., Plotnikov, E., Tretyakova, M., Eskova, D., Zhelchan, R., Schulga, A., Konovalova, E., Ziganshin, R., Orlova, A., Belousov, M., Tolmachev, V., & Larkina, M. (2026). The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99m Tc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01498

Vancouver

Deyev S, Fominykh A, Varvashenya R, Yanovich G, Bodenko V, Plotnikov E, et al. The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99m Tc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01498

BibTeX
@article{Deyev2026,
  author = {Deyev, Sergey and Fominykh, Anastasia and Varvashenya, Ruslan and Yanovich, Gleb and Bodenko, Vitalina and Plotnikov, Evgenii and Tretyakova, Mariia and Eskova, Daria and Zhelchan, Roman and Schulga, Alexey and Konovalova, Elena and Ziganshin, Rustam and Orlova, Anna and Belousov, Mikhail and Tolmachev, Vladimir and Larkina, Mariia},
  title = {The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99m Tc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01498}
}
Kostenlos starten →